1. Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milano, Italy
2. Department of Oncology and Hemato-Oncology, University of Milano, Milano
3. Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy
4. Department of Human Pathology “G. Barresi”, Medical Oncology Unit, University of Messina, Messina, Italy